Monopar Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MNPR and other ETFs, options, and stocks.About MNPR
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages.
MNPR Key Statistics
Stock Snapshot
Monopar Therapeutics(MNPR) stock is priced at $97.79, giving the company a market capitalization of 653.16M. It carries a P/E multiple of -47.32.
On 2026-07-05, Monopar Therapeutics(MNPR) stock traded between a low of $93.59 and a high of $100.00. Shares are currently priced at $97.79, which is +4.5% above the low and -2.2% below the high.
Monopar Therapeutics(MNPR) shares are trading with a volume of 187.4K, against a daily average of 194.36K.
During the past year, Monopar Therapeutics(MNPR) stock moved between $29.18 at its lowest and $105.00 at its peak.
During the past year, Monopar Therapeutics(MNPR) stock moved between $29.18 at its lowest and $105.00 at its peak.
Analyst ratings
100%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.